Making the Connection: DNA, NCD, and CMS

A National Coverage Determination (NCD) will reimburse providers for diagnostic tests using sequencing.

Today’s topic is DNA sequencing and its effect on society as a whole, on healthcare, and on Medicare. Sequencing is a laboratory procedure that maps the pattern of nucleotides in DNA.

In 2003, sequencing an individual cost $2.7 billion; by 2006, it was $300,000; and now, the entire genome can be sequenced for $700, with some tests running around $50.

There are four nucleases – cytosine, guanine, adenine, and thymine – abbreviated C-G-A-T. A sugar called deoxyribose with a phosphate group link them into a chain. Hydrogen bonds tie together two chains with base pairs of A/T and C/G.

These DNA strands are long. In only one of the 46 human chromosomes, there are around 220 million base pairs. These chains are torn apart, and the newly created sequence of nucleases helps build proteins. But the system fails some of the time. Most of the time, a failure really doesn’t matter, but sometimes it does, and in a big way. Such as with cancer. By taking the DNA of normal humans and comparing it to the DNA of humans with a special disease, it is possible to determine where the problem is.

A Genome-Wide Association Study

The BRCA gene linked to breast cancer was found this way. A single protein glitch can cause incredible problems. If your DNA at the 9p21.2 location gets messed up, then a single protein is not made, and you can get Lou Gehrig’s disease.

DNA profiling also allows for genetic fingerprinting. It is used in criminal investigations, in finding out who the father really is, or in identification of persons when there is not much left to go on, such as after an airplane crash.

Personalized medicine, or pharmacogenomics, uses genetic information to help identify optimal therapies for individual patients. It also makes it possible to find out if you may be susceptible to certain diseases.

Type 2 diabetes risk can be identified through sequencing. This gives an opportunity to change lifestyle before it is too late. Today’s current rage is the use of DNA sequencing to discover one’s ancestry. People sometimes are surprised to learn that their ancestors are from some very unexpected places. If everyone in the United States took a DNA test, they would quickly realize how mixed up everyone is, and racism would (hopefully) disappear.

In Medicare, DNA sequencing is being used for patients with advanced cancer. The current administration has finalized a National Coverage Determination (NCD) that will reimburse providers for diagnostic tests using sequencing. For example, the F1CDx test is a companion diagnostic for 15 targeted therapies. It looks for genetic mutations in 324 genes and two genomic signatures in any solid tumor.

We should all be proud that the Centers for Medicare & Medicaid Services (CMS) is covering the most advanced DNA sequencing techniques, and at the same time driving research to even greater heights.

Facebook
Twitter
LinkedIn

Edward M. Roche, PhD, JD

Edward Roche is the director of scientific intelligence for Barraclough NY, LLC. Mr. Roche is also a member of the California Bar. Prior to his career in health law, he served as the chief research officer of the Gartner Group, a leading ICT advisory firm. He was chief scientist of the Concours Group, both leading IT consulting and research organizations. Mr. Roche is a member of the RACmonitor editorial board as an investigative reporter and is a popular panelist on Monitor Mondays.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24